Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC); Notice of Meeting, 63495 [E8-25449]
Download as PDF
Federal Register / Vol. 73, No. 207 / Friday, October 24, 2008 / Notices
Dated: October 16, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–25359 Filed 10–23–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
jlentini on PROD1PC65 with NOTICES
Advisory Committee on Heritable
Disorders in Newborns and Children
(ACHDNC); Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), notice is hereby
given of the following meeting:
Name: Advisory Committee on
Heritable Disorders in Newborns and
Children.
Date And Time: November 24, 2008,
1 p.m.–4 p.m. EST
Place: Webcast.
The ACHDNC will meet on Monday,
November 24, 2008 from 1 p.m. to 4
p.m. EST. The general public can join
the meeting via webcast by logging onto
https://altarum.na3.acrobat.com/
achdnc/; next select ‘‘enter as a guest,’’
type in your full name, and click ‘‘enter
room.’’ Participants must also dial the
toll free phone number for audio (listen
only). The dial-in number is 1 (877)
705–6006; when prompted say the
password ‘‘HRSA Genetics’’.
Participants should call no later than
12:50 p.m. EST in order for the logistics
to be established for participation in the
call.
Meeting Registration: General public
participants are asked to register for the
conference by going to the registration
Web site at https://events.SignUp4.com/
ACHDNC1124. The registration
deadline is Friday, November 21, 2008.
If there are technical problems gaining
access to the call, please contact Brigitte
Abu-Hamed, Meetings Coordinator,
Conference and Meetings Management,
Altarum Institute, telephone (202) 828–
5100, or e-mail
Brigitte.AbuHamed@altarum.org.
Special Accomodations: Attendees
requiring special needs such as large
print materials or additional special
needs may make comments when
registering at the online Web site. Or
you may wish to contact Tamar R.
Shealy, Senior Meetings Manager,
Conference and Meetings Management,
Altarum Institute; telephone (202) 828–
5100, or e-mail
Tamar.Shealy@altarum.org.
Agenda: The meeting will include
presentations and continued
VerDate Aug<31>2005
16:48 Oct 23, 2008
Jkt 217001
discussions on the nomination/
evaluation process for newborn
screening candidate conditions for
review by the ACHDNC for inclusion on
the uniform newborn screening panel.
Agenda items are subject to change as
priorities dictate. You can also locate
the Agenda, presentations, and meeting
materials at the home page of the Web
site at https://events.SignUp4.com/
ACHDNC1124.
Public Comments: Members of the
public can present oral comments
during the public comment period of
the conference call. Those individuals
are required to register at the web site,
https://events.SignUp4.com/
ACHDNC1124. Requests will contain
the name, address, telephone number,
and any professional or business
affiliation of the person desiring to make
an oral presentation. Groups having
similar interests are requested to
combine their comments and present
them through a single representative.
The allocation of time may be adjusted
to accommodate the level of expressed
interest. Each public commentator will
be notified by email of their assigned
presentation time.
Members of the public are required to
submit written comments that will be
distributed to Committee members prior
to the conference call. Parties wishing to
submit written comments should ensure
that the comments are postmarked or
emailed no later than Friday, November
21, 2008, for consideration. Comments
should be submitted to Tamar R. Shealy,
Meetings Manager, Conference and
Meetings Management, Altarum
Institute, 1200 18th Street, NW., Suite
700, Washington, DC 20036; telephone
(202) 828–5100, fax (202) 785–3083, or
e-mail Tamar.Shealy@altarum.org.
For Further Information Contact:
Anyone requiring information regarding
the ACHDNC should contact: Jill F.
Shuger, M.S., Maternal and Child
Health Bureau, HRSA, Parklawn
Building, Room 18A–19, 5600 Fishers
Lane, Rockville, Maryland 20857;
telephone (301) 443–1080, fax (301)
594–0878, or e-mail jshuger@hrsa.gov.
Supplementary Information: The
ACHDNC was chartered originally
under Section 1111 of the Public Health
Service (PHS) Act, 42 U.S.C. 300b–10 in
February 2003 to advise the Secretary of
the U.S. Department of Health and
Human Services and as amended in the
Newborn Screening Saves Lives Act.
The Committee is governed by the
provisions of Public Law 92–463, as
amended (5 U.S.C. App. 2), and 41 CFR
Part 102–3, which sets forth standards
for the formation and use of advisory
committees. The ACHDNC is directed to
review and report regularly on newborn
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
63495
and childhood screening practices for
heritable disorders and to recommend
improvements in the national newborn
and childhood heritable screening
programs.
Dated: October 17, 2008.
Alexandra Huttinger,
Director, Division of Policy Review and
Coordination.
[FR Doc. E8–25449 Filed 10–23–08; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request; Simulations for Drug Related
Science Education
Summary: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institute on Drug Abuse (NIDA), the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below. This proposed
information collection was previously
published in the Federal Register on
June 26, 2008, (Vol. 73 No. 124, page
36337) and allowed 60 days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Institutes of
Health may not conduct or sponsor, and
the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after November 15,
2008, unless it displays a currently valid
OMB control number.
Proposed Collection: Title:
Simulations for Drug Related Science
Education. Type of Information
Collection Request: NEW. Need and Use
of Information Collection: This is a
request for a one-time clearance to
evaluate an interactive multimedia
module developed by ArchieMD. This
evaluation seeks to determine whether
the multimedia module ArchieMD: The
Science of Drugs (1) Increases students’
knowledge in brain and heart biology
and the effects drugs have on the body
(2) Increases positive attitudes towards
science education for high school
students (3) Reinforces or instills
negative attitudes towards substance
abuse. In order to test the effectiveness
of the interactive multimedia module,
data will be collected in the form of pre
and post test surveys from 10th and
11th grade high school students
utilizing the developed module. The
E:\FR\FM\24OCN1.SGM
24OCN1
Agencies
[Federal Register Volume 73, Number 207 (Friday, October 24, 2008)]
[Notices]
[Page 63495]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-25449]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Committee on Heritable Disorders in Newborns and
Children (ACHDNC); Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Public Law 92-463), notice is hereby given of the
following meeting:
Name: Advisory Committee on Heritable Disorders in Newborns and
Children.
Date And Time: November 24, 2008, 1 p.m.-4 p.m. EST
Place: Webcast.
The ACHDNC will meet on Monday, November 24, 2008 from 1 p.m. to 4
p.m. EST. The general public can join the meeting via webcast by
logging onto https://altarum.na3.acrobat.com/achdnc/; next select
``enter as a guest,'' type in your full name, and click ``enter room.''
Participants must also dial the toll free phone number for audio
(listen only). The dial-in number is 1 (877) 705-6006; when prompted
say the password ``HRSA Genetics''. Participants should call no later
than 12:50 p.m. EST in order for the logistics to be established for
participation in the call.
Meeting Registration: General public participants are asked to
register for the conference by going to the registration Web site at
https://events.SignUp4.com/ACHDNC1124. The registration deadline is
Friday, November 21, 2008. If there are technical problems gaining
access to the call, please contact Brigitte Abu-Hamed, Meetings
Coordinator, Conference and Meetings Management, Altarum Institute,
telephone (202) 828-5100, or e-mail Brigitte.AbuHamed@altarum.org.
Special Accomodations: Attendees requiring special needs such as
large print materials or additional special needs may make comments
when registering at the online Web site. Or you may wish to contact
Tamar R. Shealy, Senior Meetings Manager, Conference and Meetings
Management, Altarum Institute; telephone (202) 828-5100, or e-mail
Tamar.Shealy@altarum.org.
Agenda: The meeting will include presentations and continued
discussions on the nomination/evaluation process for newborn screening
candidate conditions for review by the ACHDNC for inclusion on the
uniform newborn screening panel. Agenda items are subject to change as
priorities dictate. You can also locate the Agenda, presentations, and
meeting materials at the home page of the Web site at https://
events.SignUp4.com/ACHDNC1124.
Public Comments: Members of the public can present oral comments
during the public comment period of the conference call. Those
individuals are required to register at the web site, https://
events.SignUp4.com/ACHDNC1124. Requests will contain the name, address,
telephone number, and any professional or business affiliation of the
person desiring to make an oral presentation. Groups having similar
interests are requested to combine their comments and present them
through a single representative. The allocation of time may be adjusted
to accommodate the level of expressed interest. Each public commentator
will be notified by email of their assigned presentation time.
Members of the public are required to submit written comments that
will be distributed to Committee members prior to the conference call.
Parties wishing to submit written comments should ensure that the
comments are postmarked or emailed no later than Friday, November 21,
2008, for consideration. Comments should be submitted to Tamar R.
Shealy, Meetings Manager, Conference and Meetings Management, Altarum
Institute, 1200 18th Street, NW., Suite 700, Washington, DC 20036;
telephone (202) 828-5100, fax (202) 785-3083, or e-mail
Tamar.Shealy@altarum.org.
For Further Information Contact: Anyone requiring information
regarding the ACHDNC should contact: Jill F. Shuger, M.S., Maternal and
Child Health Bureau, HRSA, Parklawn Building, Room 18A-19, 5600 Fishers
Lane, Rockville, Maryland 20857; telephone (301) 443-1080, fax (301)
594-0878, or e-mail jshuger@hrsa.gov.
Supplementary Information: The ACHDNC was chartered originally
under Section 1111 of the Public Health Service (PHS) Act, 42 U.S.C.
300b-10 in February 2003 to advise the Secretary of the U.S. Department
of Health and Human Services and as amended in the Newborn Screening
Saves Lives Act. The Committee is governed by the provisions of Public
Law 92-463, as amended (5 U.S.C. App. 2), and 41 CFR Part 102-3, which
sets forth standards for the formation and use of advisory committees.
The ACHDNC is directed to review and report regularly on newborn and
childhood screening practices for heritable disorders and to recommend
improvements in the national newborn and childhood heritable screening
programs.
Dated: October 17, 2008.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
[FR Doc. E8-25449 Filed 10-23-08; 8:45 am]
BILLING CODE 4165-15-P